Fingerprint
Dive into the research topics of 'Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
LCMC study investigators
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations